The weekly litigation news digest is live. Subscribe now

IP Verse

A Stable Parenteral Dosage Form Of Cetrorelix Acetate - EP3811927

The patent EP3811927 was granted to SUN Pharmaceutical Industries on Feb 23, 2022. The application was filed on Mar 10, 2020 under application number EP20162018A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3811927

SUN PHARMACEUTICAL INDUSTRIES
Application Number
EP20162018A
Filing Date
Mar 10, 2020
Status
Granted And Under Opposition
Oct 15, 2021
Publication Date
Feb 23, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WEICKMANN & WEICKMANNAug 12, 2022-ADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2013303464
DESCRIPTIONUS7214662
DESCRIPTIONUS7718599
OPPOSITIONEP2662073
OPPOSITIONUS2003216302
OPPOSITIONUS2013288968
OPPOSITIONUS2013303464
OPPOSITIONUS2018325993
OPPOSITIONUS7214662
OPPOSITIONUS7718599
OPPOSITIONWO0187265
OPPOSITIONWO03045419
OPPOSITIONWO2015004125
OPPOSITIONWO2021079339
SEARCHUS2013303464
SEARCHUS7718599

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents